BIOCLINICAL RESEARCH ALLIANCE INC.

What BIOCLINICAL RESEARCH ALLIANCE INC. does

Bioclinical Research Alliance Inc. (BRA) is a privately held, multi-specialty clinical research center founded in 2014 and headquartered at 7821 Coral Way, Miami, Florida. The company operates as a clinical trial site conducting Phase II–IV interventional, observational, and device medical research for pharmaceutical sponsors and Contract Research Organizations (CROs), while also delivering routine and specialty medical care to patients. Its principal product lines are Clinical Trials Services, Medical Services, On-site Laboratory Services (CLIA-licensed), and a Virtual Trial / Remote Monitoring offering.

Underlying technology is centered on conventional clinical trial operations infrastructure rather than proprietary software: CTMS, e-Regulatory, e-Source, EDC, IWRS/IVRS, virtual trial and remote monitoring capabilities, a CLIA-licensed lab, and a cold-chain storage system (-20/-70/-86 freezers, medical-grade vaccine refrigerator, dry ice access). BRA has built a 20,000+ patient database within a catchment of roughly 3.2 million residents in the greater Miami area, reporting a 96% patient recruiting rate and 1–3 day EDC entry and query turnaround.

BRA's business model is professional-services-based, with revenue generated through per-study contracts with sponsors and CROs supplemented by fee-for-service medical care to the local population. Go-to-market is hybrid: enterprise field sales to pharma sponsors and CROs for trial placement, paired with self-service and phone-based patient enrollment. The clinical staff includes 10 board-certified principal investigators and lead researchers across internal medicine, cardiology, pulmonology, neurology, psychiatry, endocrinology, rheumatology, and dermatology, supported by GCP/CPR/ACLS/IATA-trained bilingual recruitment teams. The company is privately held with no disclosed funding, parent, or institutional investors.

Name

BIOCLINICAL RESEARCH ALLIANCE INC.

Legal name

Bioclinical Research Alliance Inc.

Website

https://biocresearch.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Bioclinical Research Alliance is a Miami-based multi-specialty clinical research site founded in 2014 that conducts Phase II–IV trials for pharmaceutical sponsors and CROs and provides outpatient medical services, supported by a CLIA-licensed lab, virtual trial infrastructure, and a 20,000+ patient database.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical trial services
• Phase II-IV trials
• Clinical research site
• Patient recruitment services
• Multi-specialty research

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Trial Conduct Services: BRA operates as a clinical trial site conducting Phase II-IV medical research studies for pharmaceutical sponsors and CROs. Revenue is generated through contracts with sponsors to conduct clinical trials, including patient enrollment, study execution, and data collection services. The company has achieved a 96% recruiting rate demonstrating strong performance.
2. Medical Services: Provides medical services ranging from routine check-ups to specialized treatments tailored to each patient's needs. These services are offered as part of comprehensive healthcare delivery to patients participating in or outside of clinical trials.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

BRA operates as a dedicated clinical trial site conducting Phase II–IV medical research studies for pharmaceutical and biotechnology sponsors and CROs, including interventional, observational, and device studies. It also delivers a broader range of medical services to patients—from routine check-ups to specialized treatments—across multiple therapeutic areas. Service execution is supported by a CLIA-licensed on-site laboratory, advanced cold-chain storage, virtual trial and remote monitoring infrastructure, and a full-time bilingual clinical and recruitment team.

Product overview

Bioclinical Research Alliance Inc. operates as a multi-speciality clinical research center offering two primary integrated service lines: Clinical Trials Services (Phase II-IV) and Medical Services. The company combines on-site laboratory services (CLIA-licensed) with virtual trial and remote monitoring capabilities, supported by advanced equipment including multiple freezers, centrifuges, ECG machines, and spirometer. The facility focuses on internal medicine, cardiology, pulmonology, neurology, psychiatry, endocrine, rheumatology, and dermatology therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Services Phase II-IV clinical trial services conducting interventional, observational, and device medical research studies with a dedicated on-site recruiting centre achieving a 96% recruiting rate. The service is contracted by pharmaceutical and biotechnology sponsors and CROs.
• Medical Services Comprehensive medical services ranging from routine check-ups to specialized treatments, emphasizing individualized care, cultural sensitivity, and patient empowerment. Delivered to patients participating in or outside of clinical trials.
• On-site Laboratory Services CLIA-licensed laboratory facility for collection and shipment to central laboratory, supporting clinical trial operations with comprehensive specimen handling infrastructure.
• Virtual Trial and Remote Monitoring Virtual trial and remote monitoring capabilities enabling flexible participant engagement and decentralized trial execution, extending BRA's reach beyond its physical Miami location.

Quantifiable outcome

• 96% patient recruiting rate
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Partner organizations (logos displayed)coreOthersBRA maintains partnerships with various pharmaceutical companies and CROs as evidenced by their 'Our Partners' section displaying partner logos. Specific partner names are not disclosed on the website as the logos are presented as images without accompanying text identifying the companies.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Accel Research Sites: Accel is a multi-site clinical research organization running Phase II–IV trials across therapeutic specialties with dedicated patient recruitment teams — a direct peer to BRA's multi-specialty site model.
• Centricity Research: Centricity Research runs an integrated network of clinical trial sites across multiple therapeutic areas with embedded patient databases — comparable in operating model and customer mix to BRA.
• Flourish Research: Flourish Research is an integrated clinical trial site network serving sponsors and CROs with multi-specialty Phase II–IV capabilities — directly comparable to BRA's operating model and target customer base.
• Velocity Clinical Research: Velocity operates an integrated multi-site clinical trial network in the U.S. conducting Phase II–IV trials across multiple therapeutic areas — directly comparable to BRA's site-based, multi-specialty clinical research model, but at significantly greater scale.
• DM Clinical Research: DM Clinical Research operates a network of multi-specialty clinical trial sites with embedded patient recruitment and bilingual capabilities — closely comparable to BRA's Miami-based, Hispanic-recruitment-focused site operations.
• Benchmark Research: Benchmark Research operates multi-specialty clinical trial sites with on-site recruitment capabilities serving pharma/CRO clients — a comparable site operator to BRA in scale and service offering.
• AMR Clinical: AMR (formerly Advanced Medical Research) is a multi-specialty clinical trial site organization running Phase II–IV studies for sponsors and CROs — a comparable site-based research operator.
• S4 Clinics: S4 Clinics operates community-based clinical trial sites across multiple U.S. geographies with embedded recruitment teams — comparable to BRA's site-network growth trajectory.

Broad incumbents

• IQVIA (Site Services): IQVIA is the largest global CRO with site management and clinical trial delivery capabilities spanning all phases. It serves the same sponsor/CRO client base as BRA but at global scale, with site services as one segment of a much broader portfolio.
• Labcorp Clinical Trials: Labcorp operates central laboratories and site-support services for clinical trials, including capabilities that overlap with BRA's CLIA-licensed lab and sample-handling infrastructure — a broader incumbent in adjacent services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/100064211346775
• LinkedInlinkedin.com/company/bioclinical-research-alliance-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOCLINICAL RESEARCH ALLIANCE INC.